These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1751644

  • 1. Regional distribution of brain gangliosides in Alzheimer's disease.
    Kalanj S, Kracun I, Rosner H, Cosović C.
    Neurol Croat; 1991; 40(4):269-81. PubMed ID: 1751644
    [Abstract] [Full Text] [Related]

  • 2. Brain gangliosides in Alzheimer's disease.
    Kracun I, Kalanj S, Cosovic C, Talan-Hranilovic J.
    J Hirnforsch; 1990; 31(6):789-93. PubMed ID: 2092064
    [Abstract] [Full Text] [Related]

  • 3. Human brain gangliosides in development, aging and disease.
    Kracun I, Rosner H, Drnovsek V, Heffer-Lauc M, Cosović C, Lauc G.
    Int J Dev Biol; 1991 Sep; 35(3):289-95. PubMed ID: 1814411
    [Abstract] [Full Text] [Related]

  • 4. Cortical distribution of gangliosides in Alzheimer's disease.
    Kracun I, Kalanj S, Talan-Hranilovic J, Cosovic C.
    Neurochem Int; 1992 Apr; 20(3):433-8. PubMed ID: 1304338
    [Abstract] [Full Text] [Related]

  • 5. Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease.
    Barrier L, Ingrand S, Damjanac M, Rioux Bilan A, Hugon J, Page G.
    Neurobiol Aging; 2007 Dec; 28(12):1863-72. PubMed ID: 17007963
    [Abstract] [Full Text] [Related]

  • 6. Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.
    Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Månsson JE, Svennerholm L.
    Aging (Milano); 1992 Dec; 4(4):301-6. PubMed ID: 1294245
    [Abstract] [Full Text] [Related]

  • 7. Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains.
    Molander-Melin M, Blennow K, Bogdanovic N, Dellheden B, Månsson JE, Fredman P.
    J Neurochem; 2005 Jan; 92(1):171-82. PubMed ID: 15606906
    [Abstract] [Full Text] [Related]

  • 8. [Changes in cerebral gangliosides during long-term administration of amphetamine and haloperidol].
    Shenk Kh, Khaumer U, Kharts S, Zikh M, Khasel'khorst U.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Jan; 86(7):1021-5. PubMed ID: 3765985
    [Abstract] [Full Text] [Related]

  • 9. Ganglioside patterns in amyotrophic lateral sclerosis brain regions.
    Rapport MM, Donnenfeld H, Brunner W, Hungund B, Bartfeld H.
    Ann Neurol; 1985 Jul; 18(1):60-7. PubMed ID: 4037752
    [Abstract] [Full Text] [Related]

  • 10. Topographical atlas of the gangliosides of the adult human brain.
    Kraĉun I, Rösner H, Cosović C, Stavljenić A.
    J Neurochem; 1984 Oct; 43(4):979-89. PubMed ID: 6470716
    [Abstract] [Full Text] [Related]

  • 11. Gangliosides in rat kidney: composition, distribution, and developmental changes.
    Saito M, Sugiyama K.
    Arch Biochem Biophys; 2001 Feb 01; 386(1):11-6. PubMed ID: 11360994
    [Abstract] [Full Text] [Related]

  • 12. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.
    Cacabelos R, Alvarez XA, Fernández-Novoa L, Franco A, Mangues R, Pellicer A, Nishimura T.
    Methods Find Exp Clin Pharmacol; 1994 Mar 01; 16(2):141-51. PubMed ID: 8007743
    [Abstract] [Full Text] [Related]

  • 13. Abnormalities in gangliosides and other lipids of monkey, rabbit and human brains with chronic organic mercury intoxication.
    Ando S, Toyoda Y, Nagai Y, Ikuta F.
    Jpn J Exp Med; 1985 Feb 01; 55(1):1-6. PubMed ID: 3928950
    [Abstract] [Full Text] [Related]

  • 14. Gangliosides in the brain in adult Down's syndrome and Alzheimer's disease.
    Brooksbank BW, McGovern J.
    Mol Chem Neuropathol; 1989 Dec 01; 11(3):143-56. PubMed ID: 2534985
    [Abstract] [Full Text] [Related]

  • 15. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S, Poirier J, Guevara J, Dea D, Hawkes C, Robitaille Y, Quirion R.
    Neurobiol Aging; 2006 Feb 01; 27(2):199-210. PubMed ID: 16399207
    [Abstract] [Full Text] [Related]

  • 16. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
    Beal MF, Mazurek MF, Svendsen CN, Bird ED, Martin JB.
    Ann Neurol; 1986 Oct 01; 20(4):489-95. PubMed ID: 3789664
    [Abstract] [Full Text] [Related]

  • 17. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q, Jiang K, Liu Y, Zhang M, Xiao S, Zuo C, Huang H.
    Zhonghua Yi Xue Za Zhi; 2002 Dec 10; 82(23):1613-6. PubMed ID: 12667368
    [Abstract] [Full Text] [Related]

  • 18. Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study.
    Rezaie P, Pontikis CC, Hudson L, Cairns NJ, Lantos PL.
    J Histochem Cytochem; 2005 Aug 10; 53(8):929-40. PubMed ID: 16055747
    [Abstract] [Full Text] [Related]

  • 19. Ganglioside composition of an experimental mouse brain tumor.
    Seyfried TN, Yu RK, Saito M, Albert M.
    Cancer Res; 1987 Jul 01; 47(13):3538-42. PubMed ID: 3581087
    [Abstract] [Full Text] [Related]

  • 20. Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease.
    Pernber Z, Blennow K, Bogdanovic N, Månsson JE, Blomqvist M.
    Dement Geriatr Cogn Disord; 2012 Jul 01; 33(2-3):174-88. PubMed ID: 22572791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.